These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22424185)

  • 21. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
    Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
    Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization and in vitro antitumour activity of a series of novel platinum(II) complexes bearing Schiff base ligands.
    Proetto M; Liu W; Hagenbach A; Abram U; Gust R
    Eur J Med Chem; 2012 Jul; 53():168-75. PubMed ID: 22534185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
    Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
    ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [(C3H4N2)2Au]Cl--a bis protic gold(I)-NHC.
    Kunz PC; Wetzel C; Kögel S; Kassack MU; Spingler B
    Dalton Trans; 2011 Jan; 40(1):35-7. PubMed ID: 21076735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
    Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
    Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
    Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
    Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions.
    Rigobello MP; Messori L; Marcon G; Agostina Cinellu M; Bragadin M; Folda A; Scutari G; Bindoli A
    J Inorg Biochem; 2004 Oct; 98(10):1634-41. PubMed ID: 15458826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
    Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
    J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
    Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
    Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.
    Meier-Menches SM; Aikman B; Döllerer D; Klooster WT; Coles SJ; Santi N; Luk L; Casini A; Bonsignore R
    J Inorg Biochem; 2020 Jan; 202():110844. PubMed ID: 31739113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
    González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
    J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruthenium(III) maltolato-nitroimidazole complexes: synthesis and biological activity.
    Kennedy DC; Wu A; Patrick BO; James BR
    J Inorg Biochem; 2006 Dec; 100(12):1974-82. PubMed ID: 16938347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
    Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
    J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.